We are recruiting: Postdoctoral Fellow in Rare Disease Bioinformatics

The Polavarapu research group is recruiting a Postdoctoral Fellow in Rare Disease Bioinformatics. Working within a multidisciplinary and collaborative research environment, the postholder will provide computational and bioinformatic expertise to a team working on the integration of genomic, transcriptomic, proteomic, phenotypic, and publicly available datasets for variant interpretation, gene discovery, genotype–phenotype studies, and translational rare disease research.

The position involves close collaboration with clinicians, wet-lab scientists, bioinformaticians, and international research consortia. The successful candidate will contribute to the development and implementation of modern computational genomics workflows, including emerging AI/ML-based analytical approaches and reproducible bioinformatics pipelines.

The details for the role and application process can be found here: RI-26-032 Postdoctoral Fellow (Polavarapu)

 

PDF position with Kiran-2

Read next...

Markus A. Ruegg

Graham Mainwood Lecture – Dr. Markus A. Rüegg

The University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD)  under the co-leadership of Dr. Hanns Lochmüller is delighted to host the 2026 Graham...
Congratulations!

PhD completion – Congratulations!

Congratulations to our two graduate students Dr. Stephen Holland and Dr. Malaichamy Sivasankar on the successful defense of their PhD dissertations!   Stephen successfully defended his PhD thesis titled...
New publications alert

New Publications Alert!

Our group has recently published two new papers with the first providing insights on the impact of GFPT1 loss in cellular models and the second...
New members post - July 2026

Meet The Lochmüller group’s Newest Members!

Our group is growing! We are excited to introduce two new members who have recently joined the Lochmüller group. Claudia Wyld Clinical Research Assistant Claudia...
Kelly and Ofosu papers (4)

New Publication: Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are a group of rare inherited neuromuscular disorders. Although many forms of CMS appear similar clinically, the disease can be caused...
Adobe Express - file

Oral Platform Presentation (Undergraduate) Category Winner!

We are thrilled to share that Katerina was the winner of Undergraduate Category for her presentation titled “Novel gene discovery in congenital myasthenic syndromes using optogenetic zebrafish...